Home / Research projects / MYOCET® PROTOCOL (PHASE II)
Project objectivesUse of non-pegylated liposomal Doxorubicin (Myocet®) as second line in advanced epithelial ovarian cancer. |
Start and end date |
2007 - 2011 |
Project Manager |
Prof. Angioli Roberto - Coordinator |
Coordinating institution of the project |
UCBM |